Pfizer
Pfizer Oncology RCC application
The Pfizer Oncology RCC application has been developed to support UK Healthcare Professionals responsible for the diagnosis and treatment of metastatic renal cell carcinoma (mRCC).
The easy-to-use Patient Prognosis Criteria tool allows Healthcare Professionals to establish a prognosis for their patient based upon five key risk factors for mRCC, as identified by Motzer et al.*
Simply answer Yes or No, to the relevant statements using the sliders to receive confirmation of whether your patient has a favourable, intermediate or poor prognosis according to the criteria.
